What if we could predict psoriatic arthritis before it even begins? In this episode of Inside GRAPPA, host Dr. Hanna Johnsson is joined by Professors Oliver Fitzgerald and Steve Pennington to discuss the groundbreaking HIPPOCRATES Project. Funded by the Innovative Healthcare Initiative, this major European research effort is tackling the biggest challenges in psoriatic arthritis (PsA)—from early diagnosis to precision treatment.

With 27 partners across academia, industry, and patient organizations, HIPPOCRATES is at the forefront of multi omics research, integrating cutting-edge genomics, proteomics, and imaging technologies to revolutionize PsA care. But what are the biggest hurdles they’ve faced? And how close are they to real-world clinical impact?

🔑 Key Takeaways

• 📌 The four major unmet needs in psoriatic arthritis and how HIPPOCRATES is addressing them.
• 📌 How patient representatives are shaping the research and ensuring its relevance.
• 📌 The role of multi omics in predicting PsA progression and improving treatment response.
• 📌 Challenges of coordinating a massive international project and the unexpected roadblocks.
• 📌 Early findings and what they mean for the future of PsA diagnosis and treatment.

📢 Resources & Links

• 🔗 Learn more about the HIPPOCRATES Project

• 🔗 Follow GRAPPA: grappanetwork.org
• 🎧 Listen now on Apple Podcasts, Spotify, or wherever you get your podcasts!

💡 Enjoying the podcast? Leave us a review and let us know what topics you’d like to hear next!

Hosted on Acast. See acast.com/privacy for more information.